Home › Funds › MFS Investment Management › NRIX
MFS Investment Management position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q1 2026)42.60K sh
Reported value held$660.35K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 21.30K | $189.11K | New |
| Q2 2023 | 20.81K | $207.85K | Reduce |
| Q3 2023 | 40.83K | $320.89K | Add |
| Q4 2023 | 142.15K | $1.47M | Add |
| Q1 2024 | 112.78K | $1.66M | Reduce |
| Q2 2024 | 98.17K | $2.05M | Reduce |
| Q3 2024 | 69.42K | $1.56M | Reduce |
| Q4 2024 | 67.40K | $1.27M | Reduce |
| Q1 2025 | 43.01K | $510.91K | Reduce |
| Q2 2025 | 43.54K | $495.97K | Add |
| Q3 2025 | 46.61K | $430.67K | Add |
| Q4 2025 | 43.74K | $829.80K | Reduce |
| Q1 2026 | 42.60K | $660.35K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- Citadel Advisors 1.53M sh · $37.10M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026